Home News EU drug regulator: Uncommon blood clot is ‘very uncommon AstraZeneca aspect impact’

EU drug regulator: Uncommon blood clot is ‘very uncommon AstraZeneca aspect impact’

41
0

The EU’s medicines regulator finds the advantages of the Covid-19 vaccine outweigh the dangers.